Want to join the conversation?
$HOT said that the company returned over $625MM through dividends and share repurchases to shareholders in FY15, exceeding the high end of its range. The company also said that so far there has been no material impact to its business from the Zika virus in the US. For FY16, $HOT expects RevPAR in China to be in the middle of its guidance range.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.